skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

99+ Total results for product and free and sample content found

Deals API : Make your strongest business decisions with high-quality, detailed deals data.

Deals API : Make your strongest business decisions with high-quality, detailed deals data.

Access granular deals data you can integrate into your own data systems for a complete, informed view of markets, companies, and therapy areas.

Topic Market Intelligence deal-trends

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Coronavirus Update: Regeneron Races Into Phase III Trial Of Antibodies To Block Coronavirus Infection

Plus Updates On Mylan, Sinovac, Zydus Cadila

Topic Coronavirus clinical-trials research

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Operation Warp Speed Spreads Its Bets With 1.6bn Novavax Deal

Novavax has progressed into Phase I trials with relatively little funding, but backing from Operation Warp Speed makes it a stronger contender.

Topic Coronavirus business-strategies

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

2020 Titans Of Pharma Infographic

Scrip’s eagerly awaited annual snapshot of pharma leadership in 2020 is here. The 2020 Titans of Pharma infographic features key information on the industry’s top leaders and the mega companies they oversee.

Topic Leadership Market Access

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Titans of Pharma 2020: A Bumper Year For Top Executive Compensation

CEO pay at the top 15 pharma companies increased by 3.9% in 2019. But how did that match up to company performance? Read the article now available from Scrip and learn who were the big winners, and how their companies performed financially.

Topic Leadership company-analysis Market Access

Skipta

The Impact of Covid-19 on B2B Marketers

When circumstances make meeting in person an impossibility, Skipta Gather is there. Don’t miss out on reaching your target audience because travel is curtailed and meetings are cancelled. Use Skipta Gather to conduct virtual sessions with verified physicians and get the job done.

Topic Advertising, Marketing & Sales

Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biom...

COVID-19 and the impact on the clinical trial space

COVID-19 and the impact on the clinical trial space

The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

Topic Coronavirus clinical-trials

awareness, Pharma consulting: 医療用医薬品のコンサルティング

Hunting for Cancer Neoantigens : What is the best approach?

Important insights into neoantigen-based immunotherapies and which developers are leading in this growing area.

Topic cancer clinical-trial-optimization

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine

Pfizer CEO Bourla Wants Profit From COVID-19 Vaccine logo

Several countries already are calling about orders, as the company prepares to begin a Phase III trial of its mRNA coronavirus vaccine candidate.

Topic Coronavirus Vaccines

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。